The elevation of circulating fibroblast growth factor 23 without kidney disease does not increase cardiovascular disease risk

Autor: Pastor-Arroyo, Eva-Maria, Gehring, Nicole, Krudewig, Christiane, Costantino, Sarah, Bettoni, Carla, Knöpfel, Thomas, Sabrautzki, Sibylle, Lorenz-Depiereux, Bettina, Pastor, Johanne, Strom, Tim M., Hrabě de Angelis, Martin, Camici, Giovanni G., Paneni, Francesco, Wagner, Carsten A., Rubio-Aliaga, Isabel
Zdroj: In Kidney International July 2018 94(1):49-59
Databáze: ScienceDirect